Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
To aid the effort to develop a vaccine for the novel coronavirus that originated in China, GlaxoSmithKline has agreed to make its vaccine adjuvant technology available to the nonprofit Coalition for Epidemic Preparedness Innovation. CEPI-funded groups developing vaccines for the virus—such as the University of Queensland—will have access to GSK adjuvants. Adjuvants are chemicals added to vaccines to boost their efficacy.
This article has been sent to the following recipient: